🔗 Visit the ClinicalTrials.gov page for NCT01954693
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Lessons learned from studying syndromic autism spectrum disorders. | Nat Neurosci | 2016 | 1.04 |
| 2 | Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism. | Neurotherapeutics | 2015 | 0.87 |
| 3 | Impaired Mitochondrial Dynamics and Mitophagy in Neuronal Models of Tuberous Sclerosis Complex. | Cell Rep | 2016 | 0.79 |